Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals.
Yokoyama K, Kino T, Nagata T, Miyayama T, Shibata K, Fukuda H, Yamauchi R, Fukunaga A, Umeda K, Takata K, Tanaka T, Shakado S, Sakisaka S, Imafuku S, Hirai F. Yokoyama K, et al. Among authors: imafuku s. Intern Med. 2023 Dec 15;62(24):3631-3636. doi: 10.2169/internalmedicine.1671-23. Epub 2023 Apr 28. Intern Med. 2023. PMID: 37121750 Free PMC article.
Prevalence of human T-lymphotropic virus type I in patients with psoriasis and its effect on treatment choice: A multicenter observational study.
Yonekura K, Tsuruta N, Miyagi T, Koike Y, Higashi Y, Nakahara T, Ohata C, Kaneko S, Yamaguchi M, Saito K, Yanase T, Imafuku S. Yonekura K, et al. Among authors: imafuku s. J Dermatol Sci. 2023 Jun;110(3):103-106. doi: 10.1016/j.jdermsci.2023.05.003. Epub 2023 May 12. J Dermatol Sci. 2023. PMID: 37236840 No abstract available.
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary.
Armstrong AW, Gooderham M, Warren RB, Papp KA, Strober B, Thaçi D, Morita A, Szepietowski JC, Imafuku S, Colston E, Throup J, Kundu S, Schoenfeld S, Linaberry M, Banerjee S, Blauvelt A. Armstrong AW, et al. Among authors: imafuku s. Immunotherapy. 2023 Aug;15(12):963-973. doi: 10.2217/imt-2023-0061. Epub 2023 May 7. Immunotherapy. 2023. PMID: 37150952 Free article. Review.
Systemic therapy for psoriasis and the risk of cutaneous infections.
Higashi Y, Imafuku S, Tsuruta N, Murotani K; Western Japan Inflammatory Skin Disease Research Group. Higashi Y, et al. Among authors: imafuku s. J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17245. Online ahead of print. J Dermatol. 2024. PMID: 38660962
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial.
Imafuku S, Okubo Y, Tada Y, Ohtsuki M, Colston E, Napoli A, Shao Y, Banerjee S, Morita A. Imafuku S, et al. J Dermatol. 2024 Mar;51(3):365-379. doi: 10.1111/1346-8138.17074. Epub 2024 Jan 24. J Dermatol. 2024. PMID: 38268101 Clinical Trial.
199 results